Ireland
--:--IST
Latest
Clinical Trials in France / NCT05051254
Recruiting Not applicable

Respiratory Muscles and Work of Breathing in Children

NCT05051254 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2022-01-19
Last updated
2026-04-03

Condition(s) studied

Neuromuscular DiseasesCongenital Diaphragmatic HerniaLung DiseasesCardiac DiseasesScoliosisDiaphragmatic ImpairmentRespiratory Muscle Impairment

Investigational drug(s) / intervention(s)

Esogastric pressure measurement

Esogastric pressure measurement: Measurement of work of breathing and respiratory muscles strength using an esogastric catheter. One measurement or before and after (6 months and 1 year) the initiation of a pharmacological treatment in order to assess the effect of the treatment on respiratory muscle function.

Study summary

Respiratory muscle testing allows a quantitative assessment of inspiratory and expiratory muscles in children of any age with primary or secondary respiratory muscle impairment, in order to better understand the pathophysiology of respiratory impairment and guide therapeutic management. The use of an invasive technique (esogastric probe) makes it possible to specifically explore the diaphragm, the accessory inspiratory muscles and the expiratory muscles in order to detect dysfunction or paralysis of these muscles, and to estimate the work of breathing in order to better guide the respiratory management.

The primary objective of the study is to evaluate the respiratory effort in children with primary or secondary impairment of the respiratory muscles during spontaneous breathing or during mechanical ventilation.

Eligibility

Sex
ALL
Min age
0 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * Patients aged less than 18 years old with primary or secondary impairment of respiratory muscles and followed at Necker Hospital * Patients under spontaneous breathing or noninvasive or invasive mechanical ventilation * Written informed consent Exclusion Criteria: * No social insurance * Significant psychomotor retardation * Absence of cooperation * Significant agitation * Hemodynamic instability * Acute condition or temporary drug treatments that may interfere with the results of the respiratory muscle explorations

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hôpital Necker-Enfants Malades Paris France Recruiting

More Assistance Publique - Hôpitaux de Paris trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05051254 on ClinicalTrials.gov ↗ ← All trials in France